VaxCAR001

N/A

Report date: 2024/07/31 11:36:39

Base Information

Drug NameVaxCAR001

Drug Alias NameVaxCAR001VaxCAR-001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-Programmed death-ligand 1

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxcell Bio Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesVaxcell Bio Therapeutics

Inactive CompaniesN/A

Active IndicationsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A